Cargando…
Does the antisecretory peptide AF-16 reduce lung oedema in experimental ARDS?
Background: Acute respiratory distress syndrome (ARDS) is an acute inflammatory condition with pulmonary capillary leakage and lung oedema formation. There is currently no pharmacologic treatment for the condition. The antisecretory peptide AF-16 reduces oedema in experimental traumatic brain injury...
Autores principales: | Barrueta Tenhunen, Annelie, Massaro, Fabrizia, Hansson, Hans Arne, Feinstein, Ricardo, Larsson, Anders, Perchiazzi, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968528/ https://www.ncbi.nlm.nih.gov/pubmed/31701794 http://dx.doi.org/10.1080/03009734.2019.1685029 |
Ejemplares similares
-
The antisecretory peptide AF-16 may modulate tissue edema but not inflammation in experimental peritonitis induced sepsis
por: Barrueta Tenhunen, Annelie, et al.
Publicado: (2020) -
Fluid restrictive resuscitation with high molecular weight hyaluronan infusion in early peritonitis sepsis
por: Tenhunen, Annelie Barrueta, et al.
Publicado: (2023) -
Intranasal Administration of the Antisecretory Peptide AF-16 Reduces Edema and Improves Cognitive Function Following Diffuse Traumatic Brain Injury in the Rat
por: Clausen, Fredrik, et al.
Publicado: (2017) -
Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
por: Kopecky, Jan, et al.
Publicado: (2022) -
HIGH-MOLECULAR-WEIGHT HYALURONAN—A POTENTIAL ADJUVANT TO FLUID RESUSCITATION IN ABDOMINAL SEPSIS?
por: Barrueta Tenhunen, Annelie, et al.
Publicado: (2023)